The Department of Molecular Medicine/Institute of Biotechnology (IBT) was established in 1994 to administer a program to train graduate students at the interface of basic and clinical sciences with an emphasis on biomedical research focused on discovering the molecular mechanisms underlying human disease and to serve as a platform for the development of novel treatment or prevention approaches.
The Graduate Program in Molecular Medicine was established in 1994 as a forward-looking academic program designed to train students at the interface of basic and clinical sciences. Its inception marked the first such program in the State of Texas and was rooted in the firm belief that rigorous training of scientists in the genetic and biochemical basis of human disease would provide an effective means to translate rapid advances in basic research into practical health benefits for the 21st-century public.
Now located in the South Texas Research Facility (STRF), we offer a research-oriented, interdisciplinary program of study in the areas of cancer and aging and their prevention. Specific areas of study include cell (and hormone) signaling, systems biology, gene expression, epigenetics, cell cycle and checkpoint controls, DNA damage repair and associated stress responses, and regulated protein turnover.